$AIMD
Ainos, Inc.

2020 Q2 Form 10-Q Financial Statement

#000101476320000005 Filed on August 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $484.00 $606.00
YoY Change -20.13% 142.4%
Cost Of Revenue $292.00 $563.00
YoY Change -48.13% -20.37%
Gross Profit $192.00 $43.00
YoY Change 346.51% -109.41%
Gross Profit Margin 39.67% 7.1%
Selling, General & Admin $300.5K $405.0K
YoY Change -25.8% 14.5%
% of Gross Profit 156495.83% 941762.79%
Research & Development $389.00 $50.12K
YoY Change -99.22%
% of Gross Profit 202.6% 116567.44%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $300.9K $455.1K
YoY Change -33.89% 28.67%
Operating Profit -$300.7K -$455.0K
YoY Change -33.92% 28.49%
Interest Expense $1.297K $1.522K
YoY Change -14.78% 56.42%
% of Operating Profit
Other Income/Expense, Net -$300.9K
YoY Change
Pretax Income -$302.0K -$450.0K
YoY Change -32.9% 25.0%
Income Tax
% Of Pretax Income
Net Earnings -$302.0K -$453.5K
YoY Change -33.42% 27.71%
Net Earnings / Revenue -62389.67% -74837.79%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.11 -$0.17
COMMON SHARES
Basic Shares Outstanding 39.45M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $170.0K $720.0K
YoY Change -76.39% -48.2%
Cash & Equivalents $172.8K $723.4K
Short-Term Investments
Other Short-Term Assets $10.00K $60.00K
YoY Change -83.33% 0.0%
Inventory $3.675K $9.905K
Prepaid Expenses
Receivables $751.00
Other Receivables $0.00
Total Short-Term Assets $191.8K $798.0K
YoY Change -75.96% -45.27%
LONG-TERM ASSETS
Property, Plant & Equipment $3.904K $6.384K
YoY Change -38.85% -65.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $145.2K $147.0K
YoY Change -1.26% -23.25%
TOTAL ASSETS
Total Short-Term Assets $191.8K $798.0K
Total Long-Term Assets $145.2K $147.0K
Total Assets $337.0K $945.0K
YoY Change -64.34% -42.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $290.0K $170.0K
YoY Change 70.59% -10.53%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $580.0K $480.0K
YoY Change 20.83% -5.88%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $880.9K $705.3K
YoY Change 24.89% -29.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $880.9K $705.3K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $880.9K $705.3K
YoY Change 24.89% -29.7%
SHAREHOLDERS EQUITY
Retained Earnings -$5.448M -$4.033M
YoY Change 35.09% 64.62%
Common Stock $409.2K $396.6K
YoY Change 3.16% 14.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$744.1K -$239.7K
YoY Change
Total Liabilities & Shareholders Equity $337.0K $945.0K
YoY Change -64.34% -42.71%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$302.0K -$453.5K
YoY Change -33.42% 27.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$120.0K -$320.0K
YoY Change -62.5% 3.23%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -120.0K -320.0K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 10.00K 0.000
Net Change In Cash -110.0K -320.0K
YoY Change -65.63% 3.23%
FREE CASH FLOW
Cash From Operating Activities -$120.0K -$320.0K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$120.0K -$320.0K
YoY Change -62.5% 3.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 amar Common Stock Shares Outstanding And Reserved
CommonStockSharesOutstandingAndReserved
49662450
CY2020Q2 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
578664
CY2019Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
444581
amar Repayments Of Convertible Notes Payable Related Party Debt
RepaymentsOfConvertibleNotesPayableRelatedPartyDebt
amar Repayments Of Convertible Notes Payable Related Party Debt
RepaymentsOfConvertibleNotesPayableRelatedPartyDebt
37500
amar Stock Issued During Period Value Debt
StockIssuedDuringPeriodValueDebt
amar Stock Issued During Period Value Subscription
StockIssuedDuringPeriodValueSubscription
50000
amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
93250
amar Stock Issued For Advances From Investors
StockIssuedForAdvancesFromInvestors
100000
amar Stock Issued For Advances From Investors
StockIssuedForAdvancesFromInvestors
25000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
292241
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
208727
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
751
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4495380
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4207786
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
181376
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
192298
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10218
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
18992
CY2020Q2 us-gaap Assets
Assets
336972
CY2019Q4 us-gaap Assets
Assets
596626
CY2020Q2 us-gaap Assets Current
AssetsCurrent
191811
CY2019Q4 us-gaap Assets Current
AssetsCurrent
445295
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">3.</div></div></div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;">Basis of presentation.</div> The accompanying consolidated financial statements, which should be read in conjunction with the audited financial statements and footnotes included in the Company's Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019, </div>as filed with the Securities and Exchange Commission on <div style="display: inline; font-style: italic; font: inherit;"> March 30, 2020, </div>have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do <div style="display: inline; font-style: italic; font: inherit;">not</div> include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the <div style="display: inline; font-style: italic; font: inherit;">three</div> months and <div style="display: inline; font-style: italic; font: inherit;">six</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020, </div>are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be expected for the full year ending <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020.</div></div> </td> </tr> </table></div>
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
172802
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
409039
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
409039
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1276654
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
172802
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
723441
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-236237
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-553213
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40916351
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40516351
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40916351
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40516351
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
409164
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
405164
CY2020Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
595571
CY2019Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
452040
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
292
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
563
us-gaap Cost Of Revenue
CostOfRevenue
11098
us-gaap Cost Of Revenue
CostOfRevenue
3281
CY2020Q2 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
10000
CY2019Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
100000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2020Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
141257
CY2019Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
146263
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Gross Profit
GrossProfit
192
CY2019Q2 us-gaap Gross Profit
GrossProfit
43
us-gaap Gross Profit
GrossProfit
4586
us-gaap Gross Profit
GrossProfit
1401
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1297
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1522
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2302
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
637
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
203
CY2020Q2 us-gaap Inventory Net
InventoryNet
3675
CY2019Q4 us-gaap Inventory Net
InventoryNet
4131
CY2020Q2 us-gaap Liabilities
Liabilities
880905
CY2019Q4 us-gaap Liabilities
Liabilities
753308
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
336972
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
596626
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
880905
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
753308
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12500
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1270
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1637
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-244967
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-539076
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-301966
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-453517
us-gaap Net Income Loss
NetIncomeLoss
-678845
us-gaap Net Income Loss
NetIncomeLoss
-844965
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
300861
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
455082
us-gaap Operating Expenses
OperatingExpenses
681129
us-gaap Operating Expenses
OperatingExpenses
847003
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-300669
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-455039
us-gaap Operating Income Loss
OperatingIncomeLoss
-676543
us-gaap Operating Income Loss
OperatingIncomeLoss
-845602
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1270
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1637
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14583
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32125
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
10000
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
25000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3904
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5068
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
389
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50124
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
389
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52510
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5448477
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4769632
CY2020Q2 us-gaap Revenues
Revenues
484
CY2019Q2 us-gaap Revenues
Revenues
606
us-gaap Revenues
Revenues
15684
us-gaap Revenues
Revenues
4682
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
300472
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
404958
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
680740
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
794493
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
23750
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-156682
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-543933
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
730079
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-239654
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-543933
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-156682
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40516351
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39624247
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40516351
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39444456

Files In Submission

Name View Source Status
0001014763-20-000005-index-headers.html Edgar Link pending
0001014763-20-000005-index.html Edgar Link pending
0001014763-20-000005.txt Edgar Link pending
0001014763-20-000005-xbrl.zip Edgar Link pending
amar-20200630.xml Edgar Link completed
amar-20200630.xsd Edgar Link pending
amar-20200630_cal.xml Edgar Link unprocessable
amar-20200630_def.xml Edgar Link unprocessable
amar-20200630_lab.xml Edgar Link unprocessable
amar-20200630_pre.xml Edgar Link unprocessable
exhibit31-1_06302020.htm Edgar Link pending
exhibit32-1_06302020.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q_06302020.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending